Register Form

Please fill up the form below:

JSMO 2017

This Event already finished.

Japanese Society of Medical Oncology

  • 27 Jul 2017 to 29 Jul 2017
  • Kobe International Conference Center
  • Hyōgo-ken / Japan

Whats About

Cancer has manifested itself as a bane of mankind whose treatment is not only expensive but also takes a severe toll on one’s health. In the world of internet and rapid strides made in cancer treatment, it is but logical that a platform exists where all people related in aspects of this peculiar disease come together to exchange their views and provide solution to various complexities associated with this disease. The Japanese Society of Medical Oncology Annual meeting 2017 is taking place at the Kobe Convention Centre in Junko Fukutake Hall, Okayama University with this year’s theme “The Best Cancer care- Anytime, Anywhere and for Any one”. World leading oncologists, radiologists, pathologists, nurses and patients will be present at this conference to gain and impart knowledge about the advancements in the techniques and therapy for the better care, diagnoses, treatment and after care for patients suffering from cancer of various types. This conference will be the perfect platform to raise awareness about the advancement in cancer medicine, research work and patient care which is of utmost importance for patients suffering from cancer. Be a part of JSMO annual meet 2017 and contribute by sharing your research work and studies to help in better diagnosis, treatment, care and to prevent cancer from happening.


Programme Details
  • JSM/ESMO Joint Symposium
  • Optimal treatment for metastatic colorectal cancer
  • JSMO/MOGA, KACO, CSCO, SSO Joint Symposium
  • Precision medicine, its current status and possibilities for future collaborations
  • JSMO,ASCO Joint Symposium
  • Current status of molecular targeted therapy in lung cancer
  • JSMO/ESMO Special Lecture
  • Best education for metastatic colorectal cancer
  • Special lecture
  • Current concepts and future perspective of chemotherapy for soft tissue sarcoma
  • International Sessions
  • Nation- wide basket/umbrella type study for precision medicine
  • Comprehensive symptoms screening and early palliative care
  • Emerging evidence of immune check point inhibitors in non0small cell lung cancer
  • Biomarker research and treatment strategy for metastatic colorectal cancer
  • How can we manage the International gap in development of chemotherapy for gastric cancer?
  • Chemotherapy for advanced pancreatic cancer in a new era
  • Present and future status of hereditary cancer prophylactics
  • Immunotherapy for head and neck cancer: Future direction
  • New therapeutic strategy for endocrine-refractory metastatic breast cancer
  • Recent advances in the treatment of multiple myeloma
  • Treatment of carcinoma of unknown primary: Evidence based or Science based?
  • Cancer immunotherapy- What’s the next?
  • Improving the evidence base for treating elderly patients with cancer
  • Symposiums
  • Oral supportive care in cancer- Promoting evidence based clinical practices
  • Whole person care- Care for cancer patients
  • Latest status of EGFR-RTIs in EGFR mutant NSCLSs
  • Newest knowledge in gastric cancer
  • Guidelines of molecular targeted therapies for thyroid cancer
  • Can preoperative therapy guide decisions on adjuvant systematic therapy?
  • Treatment strategy for castration resistant prostate cancer, 2017
  • Multidisciplinary approaches to soft tissue sarcoma: Current management
  • The future of immune check point therapy
  • Workshop
  • Current landscape and future perspectives of biomarker study in breast cancer